China Securities Regulatory Commission, Compilation Rules for Information Disclosures by Companies That Offer Securities to the Public No. 25: Guidelines for the Content and Format of Prospectuses of Companies That Engage in Pharmaceutical and Medical Device Business

中国证券监督管理委员会公开发行证券的公司信息披露编报规则第25号——从事药品及医疗器械业务的公司招股说明书内容与格式指引

August 19, 2022 | BY

Susan Mok

CSRC sets forth disclosure requirements for listed pharma companies.

Issued: July 29, 2022

Effective: as of date of issuance

 

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]